New study screens diabetics for hidden heart risks
NCT ID NCT04866667
First seen Apr 20, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study screened 316 people with type 2 diabetes who were at high risk for heart disease. Researchers tested whether the drug liraglutide could help prevent new heart problems like chest pain, stroke, or heart attack. The goal was to better identify and manage heart disease risk in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhejiang provincial people's hospital
Hangzhou, Zhejiang, 310014, China
Conditions
Explore the condition pages connected to this study.